{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:32:33Z","timestamp":1770471153393,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370618"],"award-info":[{"award-number":["82370618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160124"],"award-info":[{"award-number":["82160124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100641"],"award-info":[{"award-number":["82100641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302067"],"award-info":[{"award-number":["82302067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203658"],"award-info":[{"award-number":["82203658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Study Program of Corps Science and Technology","award":["2022AB024"],"award-info":[{"award-number":["2022AB024"]}]},{"name":"Project of Science and Technology Department of Xinjiang Autonomous Region","award":["2022E02044"],"award-info":[{"award-number":["2022E02044"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021QH276"],"award-info":[{"award-number":["ZR2021QH276"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021QH074"],"award-info":[{"award-number":["ZR2021QH074"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QC179"],"award-info":[{"award-number":["ZR2023QC179"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH265"],"award-info":[{"award-number":["ZR2020QH265"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hepatocyte growth factor (HGF)\/c-Met signaling critically influences liver fibrosis, but its interaction with neuropilin-1 (NRP-1) in hepatocytes remains unclear. We investigated the role of hepatocyte-specific NRP-1 deletion in liver fibrosis progression and its relationship with the HGF\/c-Met pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Hepatocyte-specific NRP-1 knockout mice were generated using the Cre-lox system, and liver fibrosis was induced by carbon tetrachloride injections or a methionine- and choline-deficient diet. Fibrosis severity, hepatocyte injury, and cytokine secretion were evaluated via histology, biochemical assays, and molecular analyses in isolated hepatocytes. In vitro experiments were conducted in primary hepatocytes and Huh7 cells using lentiviral overexpression and knockdown of NRP-1. Chromatin immunoprecipitation and dual-luciferase reporter assays were performed to analyze transcription factor binding to the NRP-1 promoter.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Hepatocyte NRP-1 expression increased significantly during liver fibrosis and was positively correlated with HGF\/c-Met expression and fibrosis severity. In vivo, NRP-1 inhibition reduced extracellular matrix accumulation and abnormal angiogenesis in Alb-Cre NRP-1<jats:sup>f\/f<\/jats:sup> mice. In vitro, NRP-1 blockade inhibited c-Met activation and reduced transforming growth factor-beta and vascular endothelial growth factor secretion in hepatocytes. NRP-1 functioned as a co-receptor for HGF\/c-Met, with HGF upregulating NRP-1 expression at transcript and protein levels. NRP-1 promoted fibrosis through the Met\/extracellular signal-regulated kinase pathway. Furthermore, HGF increased retinoic acid receptor alpha expression, promoting NRP-1 transcription.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>HGF-induced upregulation of hepatocyte NRP-1, mediated by RARA binding to its promoter, drives liver fibrosis through c-Met pathway activation, highlighting NRP-1 as a potential therapeutic target for liver fibrosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00535-025-02262-8","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T13:19:50Z","timestamp":1748265590000},"page":"1000-1013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interaction of neuropilin-1 and hepatocyte growth factor\/C-Met pathway in liver fibrosis progression in hepatocyte-specific NRP-1 knockout mice"],"prefix":"10.1007","volume":"60","author":[{"given":"Han","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanran","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghao","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaomiao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianni","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-9724","authenticated-orcid":false,"given":"Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"2262_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398:1359\u201376.","journal-title":"Lancet"},{"key":"2262_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1499","volume":"13","author":"J Berumen","year":"2021","unstructured":"Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: pathophysiology and clinical implications. Wires Mech Dis. 2021;13: e1499.","journal-title":"Wires Mech Dis"},{"key":"2262_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/cells9040929","volume":"9","author":"E Lafoz","year":"2020","unstructured":"Lafoz E, Ruart M, Anton A, Oncins A, Hern\u00e1ndez-Gea V. The endothelium is a driver of liver fibrosis and regeneration. Cells. 2020;9:929.","journal-title":"Cells"},{"key":"2262_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2262_CR5","doi-asserted-by":"crossref","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020; 9.","DOI":"10.3390\/cells9040875"},{"key":"2262_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.671640","volume":"12","author":"P Acharya","year":"2021","unstructured":"Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular mechanisms of liver fibrosis. Front Pharmacol. 2021;12: 671640.","journal-title":"Front Pharmacol"},{"key":"2262_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s11033-020-05290-0","volume":"47","author":"M Zadorozhna","year":"2020","unstructured":"Zadorozhna M, Di Gioia S, Conese M, Mangieri D. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Mol Biol Rep. 2020;47:2279\u201388.","journal-title":"Mol Biol Rep"},{"key":"2262_CR8","doi-asserted-by":"publisher","first-page":"1083780","DOI":"10.3389\/fimmu.2022.1083780","volume":"13","author":"J Gong","year":"2022","unstructured":"Gong J, Tu W, Liu J, Tian D. Hepatocytes: a key role in liver inflammation. Front Immunol. 2022;13:1083780.","journal-title":"Front Immunol"},{"key":"2262_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2262_CR10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fcell.2020.00662","volume":"8","author":"A DuMond","year":"2020","unstructured":"DuMond A, Pag\u00e8s G. Neuropilins, as relevant oncology target: their role in the tumoral microenvironment. Front Cell Dev Biol. 2020;8:662.","journal-title":"Front Cell Dev Biol"},{"key":"2262_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3350\/cmh.2022.0425","volume":"29","author":"P Fern\u00e1ndez-Palanca","year":"2023","unstructured":"Fern\u00e1ndez-Palanca P, Payo-Seraf\u00edn T, M\u00e9ndez-Blanco C, San-Miguel B, Tu\u00f1\u00f3n MJ, Gonz\u00e1lez-Gallego J, Mauriz JL. Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications. Clin Mol Hepatol. 2023;29:293\u2013319.","journal-title":"Clin Mol Hepatol"},{"key":"2262_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1158\/1535-7163.MCT-05-0538","volume":"5","author":"LM Ellis","year":"2006","unstructured":"Ellis LM. The role of neuropilins in cancer. Mol Cancer Ther. 2006;5:1099\u2013107.","journal-title":"Mol Cancer Ther"},{"key":"2262_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13046-016-0291-5","volume":"35","author":"L Li","year":"2016","unstructured":"Li L, Jiang X, Zhang Q, Dong X, Gao Y, He Y, Qiao H, Xie F, Xie X, Sun X. Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors. J Exp Clin Cancer Res. 2016;35:16.","journal-title":"J Exp Clin Cancer Res"},{"key":"2262_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11523-016-0422-0","volume":"11","author":"C Hu","year":"2016","unstructured":"Hu C, Jiang X. Role of NRP-1 in VEGF-VEGFR2-independent tumorigenesis. Target Oncol. 2016;11:501\u20135.","journal-title":"Target Oncol"},{"key":"2262_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/febs.16119","volume":"289","author":"G Colotti","year":"2022","unstructured":"Colotti G, Failla CM, Lacal PM, Ungarelli M, Ruffini F, Di Micco P, Orecchia A, Morea V. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1. FEBS J. 2022;289:183\u201398.","journal-title":"FEBS J"},{"key":"2262_CR16","doi-asserted-by":"publisher","first-page":"1212577","DOI":"10.3389\/fimmu.2023.1212577","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Guo Z, Song M, Pan Q, Zhao J, Huang Y, Han Y, Ouyang D, Yang C, Chen H, Di M. Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRbeta complex in hepatocellular carcinoma. Front Immunol. 2023;14:1212577.","journal-title":"Front Immunol"},{"key":"2262_CR17","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1172\/JCI41203","volume":"120","author":"S Cao","year":"2010","unstructured":"Cao S, Yaqoob U, Das A, Shergill U, Jagavelu K, Huebert RC, Routray C, Abdelmoneim S, Vasdev M, Leof E, Charlton M. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF\/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 2010;120:2379\u201394.","journal-title":"J Clin Invest"},{"key":"2262_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ebiom.2019.04.050","volume":"43","author":"LE Wang","year":"2019","unstructured":"Wang LE, Feng Y, Xie X, Wu H, Su XN, Qi J, Xin W, Gao L, Zhang Y, Shah VH, Zhu Q. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K\/Akt pathway in hepatic sinusoidal endothelial cells. EBioMedicine. 2019;43:525\u201336.","journal-title":"EBioMedicine"},{"key":"2262_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3892\/etm.2012.803","volume":"5","author":"J Xu","year":"2013","unstructured":"Xu J, Xia J. NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo. Exp Ther Med. 2013;5:150\u20134.","journal-title":"Exp Ther Med"},{"key":"2262_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4149\/neo_2020_200914N982","volume":"68","author":"LI Xun","year":"2021","unstructured":"Xun LI, Yongqiang ZH, JinJing HU, Zhongtian BA, Wenbo ME, Xiaojing SO, Yongjian WE, Jun YA, Yihua ZH. Loss of neuropilin 1 inhibits liver cancer stem cells population and blocks metastasis in hepatocellular carcinoma via epithelial-mesenchymal transition. Neoplasma. 2021;68:325\u201333.","journal-title":"Neoplasma"},{"key":"2262_CR21","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/HEP.0000000000000320","volume":"78","author":"Q Wu","year":"2023","unstructured":"Wu Q, Pan C, Zhou Y, Wang S, Xie L, Zhou W, Ding L, Chen T, Qian J, Su R, Gao X. Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4\u20131BB agonist for liver cancer treatment. Hepatology. 2023;78:1402\u201317.","journal-title":"Hepatology"},{"key":"2262_CR22","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1038\/s41388-021-01863-w","volume":"40","author":"J Fu","year":"2021","unstructured":"Fu J, Su X, Li Z, Deng L, Liu X, Feng X, Peng J. HGF\/c-MET pathway in cancer: from molecular characterization to clinical evidence. Oncogene. 2021;40:4625\u201351.","journal-title":"Oncogene"},{"key":"2262_CR23","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-12-2791","volume":"19","author":"L Goyal","year":"2013","unstructured":"Goyal L, Muzumdar MD, Zhu AX. Targeting the HGF\/c-MET pathway in hepatocellular carcinoma. Clin Cancer Res. 2013;19:2310\u20138.","journal-title":"Clin Cancer Res"},{"key":"2262_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.808855","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Ye W, Wang YD, Chen WD. HGF\/c-met: A key promoter in liver regeneration. Front Pharmacol. 2022;13: 808855.","journal-title":"Front Pharmacol"},{"key":"2262_CR25","first-page":"971","volume":"58","author":"N Tekkesin","year":"2011","unstructured":"Tekkesin N, Taga Y, Sav A, Almaata I, \u0130brisim D. Induction of HGF and VEGF in hepatic regeneration after hepatotoxin-induced cirrhosis in mice. Hepatogastroenterology. 2011;58:971\u20139.","journal-title":"Hepatogastroenterology"},{"key":"2262_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12893-019-0664-8","volume":"20","author":"K Hoffmann","year":"2020","unstructured":"Hoffmann K, Nagel AJ, Tanabe K, Fuchs J, Dehlke K, Ghamarnejad O, Lemekhova A, Mehrabi A. Markers of liver regeneration-the role of growth factors and cytokines: a systematic review. BMC Surg. 2020;20:31.","journal-title":"BMC Surg"},{"key":"2262_CR27","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4155\/fmc-2021-0128","volume":"13","author":"G Gupta","year":"2021","unstructured":"Gupta G, Al-Malki WH, Kazmi I, Thangavelu L, Gupta PK, Jha NK, Prasher P, Singh SK, Dua K. The role of HGF\/MET in liver cancer. Future Med Chem. 2021;13:1829\u201332.","journal-title":"Future Med Chem"},{"key":"2262_CR28","doi-asserted-by":"crossref","unstructured":"Burbano de Lara S, Kemmer S, Biermayer I, Feiler S, Vlasov A, D\u2019Alessandro LA, Helm B, M\u00f6lders C, Dieter Y, Ghallab A, Hengstler JG. Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease. Mol Syst Biol. 2024; 20:187\u2013216.","DOI":"10.1038\/s44320-023-00007-4"},{"key":"2262_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-022-02475-2","volume":"41","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Xie M, Ji X, Luo X, Chen X, Zhang B, Liu D, Feng Y, Sun M, Huang W. HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. J Exp Clin Cancer Res. 2022;41:275.","journal-title":"J Exp Clin Cancer Res"},{"key":"2262_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fcell.2020.00055","volume":"8","author":"H Wang","year":"2020","unstructured":"Wang H, Rao B, Lou J, Li J, Liu Z, Li A, Cui G, Ren Z, Yu Z. The function of the HGF\/c-met axis in hepatocellular carcinoma. Front Cell Dev Biol. 2020;8:55.","journal-title":"Front Cell Dev Biol"},{"key":"2262_CR31","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.3748\/wjg.v24.i33.3695","volume":"24","author":"JA Garc\u00eda-Vilas","year":"2018","unstructured":"Garc\u00eda-Vilas JA, Medina M\u00c1. Updates on the hepatocyte growth factor\/c-Met axis in hepatocellular carcinoma and its therapeutic implications. World J Gastroenterol. 2018;24:3695\u2013708.","journal-title":"World J Gastroenterol"},{"key":"2262_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan M, Goldstein I. Protocol for primary mouse hepatocyte isolation. Star Protoc. 2020;1: 100086.","journal-title":"Star Protoc"},{"key":"2262_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12916-021-02085-3","volume":"19","author":"X Xie","year":"2021","unstructured":"Xie X, Lv H, Liu C, Su X, Yu Z, Song S, Bian H, Tian M, Qin C, Qi J, Zhu Q. HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis. BMC Med. 2021;19:247.","journal-title":"BMC Med"},{"key":"2262_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","volume":"18","author":"GK Michalopoulos","year":"2021","unstructured":"Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18:40\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2262_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","volume":"18","author":"J Gracia-Sancho","year":"2021","unstructured":"Gracia-Sancho J, Caparr\u00f3s E, Fern\u00e1ndez-Iglesias A, Franc\u00e9s R. Role of liver sinusoidal endothelial cells in liver diseases. Nat Rev Gastroenterol Hepatol. 2021;18:411\u201331.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2262_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s13287-020-01895-1","volume":"11","author":"C Hu","year":"2020","unstructured":"Hu C, Zhao L, Zhang L, Bao Q, Li L. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11:377.","journal-title":"Stem Cell Res Ther"},{"key":"2262_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/liv.13495","volume":"38","author":"H Zhu","year":"2018","unstructured":"Zhu H, Jiang X, Zhou X, Dong X, Xie K, Yang C, Jiang H, Sun X, Lu J. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells. Liver Int. 2018;38:125\u201335.","journal-title":"Liver Int"},{"key":"2262_CR38","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1038\/s41467-019-11580-4","volume":"10","author":"X Huang","year":"2019","unstructured":"Huang X, Ye Q, Chen M, Li A, Mi W, Fang Y, Zaytseva YY, O\u2019Connor KL, Vander Kooi CW, Liu S, She QB. N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals. Nat Commun. 2019;10:3708.","journal-title":"Nat Commun"},{"key":"2262_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ctrv.2013.02.001","volume":"39","author":"GV Scagliotti","year":"2013","unstructured":"Scagliotti GV, Novello S, von Pawel J. The emerging role of MET\/HGF inhibitors in oncology. Cancer Treat Rev. 2013;39:793\u2013801.","journal-title":"Cancer Treat Rev"},{"key":"2262_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/biomedicines3010046","volume":"3","author":"G Viticchi\u00e8","year":"2015","unstructured":"Viticchi\u00e8 G, Muller PAJ. c-Met and other cell surface molecules: interaction, activation, and functional consequences. Biomedicines. 2015;3:46\u201370.","journal-title":"Biomedicines"},{"key":"2262_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/hep.27402","volume":"61","author":"N Shang","year":"2015","unstructured":"Shang N, Arteaga M, Zaidi A, Stauffer J, Cotler SJ, Zeleznik-Le NJ, Zhang J, Qiu W. FAK is required for c-Met\/beta-catenin-driven hepatocarcinogenesis. Hepatology. 2015;61:214\u201326.","journal-title":"Hepatology"},{"key":"2262_CR42","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, Lemma RB, Lucas J, Ch\u00e8neby J, Baranasic D, Khan A. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2024;52:D174\u201382.","journal-title":"Nucleic Acids Res"},{"key":"2262_CR43","doi-asserted-by":"publisher","first-page":"C1697","DOI":"10.1152\/ajpcell.00012.2024","volume":"326","author":"D Xing","year":"2024","unstructured":"Xing D, Zhang W, Cui W, Yao X, Xiao Y, Chen L, Yuan S, Duan Y, Yu W, Pan P, L\u00fc Y. SIRT4 promotes neuronal apoptosis in models of Alzheimer\u2019s disease via the STAT2-SIRT4-mTOR pathway. Am J Physiol Cell Physiol. 2024;326:C1697\u2013709.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2262_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41419-018-0877-2","volume":"9","author":"T Li","year":"2018","unstructured":"Li T, Huang H, Shi G, Zhao L, Li T, Zhang Z, Liu R, Hu Y, Liu H, Yu J, Li G. TGF-beta1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition. Cell Death Dis. 2018;9:849.","journal-title":"Cell Death Dis"},{"key":"2262_CR45","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.7150\/thno.43198","volume":"10","author":"L Fan","year":"2020","unstructured":"Fan L, Lei H, Zhang S, Peng Y, Fu C, Shu G, Yin G. Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10. Theranostics. 2020;10:5895\u2013913.","journal-title":"Theranostics"},{"key":"2262_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ccr.2009.12.042","volume":"17","author":"JH Martens","year":"2010","unstructured":"Martens JH, Brinkman AB, Simmer F, Francoijs KJ, Nebbioso A, Ferrara F, Altucci L, Stunnenberg HG. PML-RARalpha\/RXR alters the epigenetic landscape in acute promyelocytic leukemia. Cancer Cell. 2010;17:173\u201385.","journal-title":"Cancer Cell"},{"key":"2262_CR47","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1182\/blood.2020005698","volume":"137","author":"Y Tan","year":"2021","unstructured":"Tan Y, Wang X, Song H, Zhang Y, Zhang R, Li S, Jin W, Chen S, Fang H, Chen Z, Wang K. A PML\/RARalpha direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia. Blood. 2021;137:1503\u201316.","journal-title":"Blood"},{"key":"2262_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-018-0796-y","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, Wu Y, Li X, Li X, Li G, Zeng Z. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. Mol Cancer. 2018;17:45.","journal-title":"Mol Cancer"},{"key":"2262_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8:455.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-025-02262-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:22:35Z","timestamp":1757179355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-025-02262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1007\/s00535-025-02262-8","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}